SCHEMBL29607696

SCHEMBL29607696

COCCOC(=O)c1cccc(-c2noc(-c3ccccc3F)n2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 14/20 0.77
RAB9A P51151 13/20 0.77
MAOA P21397 1/20 0.65
BLVRB P30043 1/20 0.65
HDAC6 Q9UBN7 1/20 0.65
SMN1; SMN2 Q16637 6/20 0.52
KMT2A Q03164 6/20 0.52
MEN1 O00255 5/20 0.52
NFKB1 P19838 4/20 0.52
NFKB2 Q00653 4/20 0.52
RELA Q04206 4/20 0.52
MAPK1 P28482 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
PKM P14618 2/20 0.52
TP53 P04637 2/20 0.51
MAPT P10636 2/20 0.51
ALDH1A1 P00352 5/20 0.48
HPGD P15428 4/20 0.48
HSD17B10 Q99714 3/20 0.48
KDM4E B2RXH2 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60513 1.00 NPC1 (0.77) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL30153302 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL29606585 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL59588 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60719 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60583 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL29607605 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60102 0.97 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
Ethane SCHEMBL25325513 0.96 NPC1 (0.71) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL12172093 0.89 NPC1 (0.69) NPC1RAB9AMAOABLVRBHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3889142-B1 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE PTC THERAPEUTICS INC (US) 2022-06-15 EP disclosed